Prevalence of Metabolic Syndrome in Atahualpa

Evaluation of the Prevalence of Metabolic Syndrome in Atahualpa Residents Aged 40 Years or More.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01770054

Enrollment

517

Registered

2013-01-17

Start date

2013-01-31

Completion date

2013-03-31

Last updated

2013-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Keywords

metabolic syndrome, diabetes mellitus

Brief summary

A recent epidemiologic survey demonstrated a high prevalence of type 2 diabetes mellitus in Atahualpa residents. Now, the investigators attempt to evaluate the prevalence of the metabolic syndrome in adults aged 40 years or more living in this rural village of coastal Ecuador.

Detailed description

Several studies have shown that the occurrence of the metabolic syndrome is a risk factor for the development of cerebrovascular and ischemic heart disease. To evaluate the prevalence of the metabolic syndrome, we will invite all Atahualpa residents aged 40 years or more to participate in this study. For the purposes of this study we will obtain the waist circumference of all individuals, will measure their blood pressure using a standard protocol, and will take a blood sample to determine fasting glucose levels, HDL cholesterol levels, triglyceride levels, and plasma insulin levels.

Interventions

OTHERobtention of a blood sample

a blood sample will be obtained to measure glucose, HDL cholesterol, triglycerides, and for genetic testing

Study design

Observational model

ECOLOGIC_OR_COMMUNITY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

40 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Atahualpa resident aged 40 years or more

Exclusion criteria

* non-consenting persons

Design outcomes

Primary

Measure	Time frame	Description
Prevalence of metabolic syndrome	5 months	determination of the metabolic syndrome in subjects aged 40 years or more

Secondary

Measure	Time frame	Description
Genetic testing	5 months	Blood will be taken to evaluate the ADN pattern of this population, to compare with other Amerindian populations with a proven high prevalence of diabetes mellitus and metabolic syndrome

Other

Measure	Time frame	Description
determination of the prevalence of hyperinsulinemia	5 months	plasma insulin levels will be determined

Countries

Ecuador

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026